Across TCGA pan-cancer cohorts, SOWAHD Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SOWAHD data layer compared with 25 for mass-spec protein and 2 for mass-spec protein.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher SOWAHD Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SOWAHD expression acts as an unfavorable survival marker.
DLBC are the cancer types where SOWAHD Mutation most reproducibly stratifies survival.